SCHEMBL20371845

SCHEMBL20371845

C[C@H](NCc1noc(C(C)(C)C)n1)c1ccc(-c2ccnc3[nH]nc(N[C@@H]4CCN(C=O)C4)c23)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20371774 1.00 — —
SCHEMBL20371873 0.88 JAK3 (0.39) —
SCHEMBL20371871 0.88 JAK3 (0.39) —
SCHEMBL20359558 0.86 BTK (0.37) —
SCHEMBL20359022 0.86 BTK (0.37) —
SCHEMBL20359023 0.86 BTK (0.37) —
SCHEMBL20371828 0.84 BTK (0.43) —
SCHEMBL20358446 0.76 BTK (0.59) —
SCHEMBL20358539 0.75 JAK3 (0.42) —
SCHEMBL20359303 0.75 JAK3 (0.42) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180194762-A1 PYRAZOLO[3,4-b]PYRIDINE AND PYRROLO[2,3-b]PYRIDINE INHIBITORS OF BRUTON'S TYROSINE KINASE PHARMACYCLICS LLC (US) 2018-07-12 — — US disclosed
Send feedback